The awareness layer for human physiology.
A patented platform that turns continuous biometric data into in-the-moment awareness. We are raising to convert an issued patent and a finished platform into an Apple Vision Pro launch.
You cannot act on what you cannot perceive.
Awareness of physiological activity is the wedge to self-directed wellness and performance. BAM renders it through a four-state color scale and a closed loop that tracks, evaluates, adapts, and re-measures — positioned to make awareness the default interface to physiology, beginning on Apple Vision Pro.
The world already trusts this language. We turned it inward.
Green, yellow, orange, red — the most widely understood signal grammar civilization has produced has only ever pointed outward. BAM's patented innovation points it at the one system that matters most: the body keeping you alive.
GreenParasympathetic · baseline · recovery · growth
YellowMild activation · worth noticing
OrangeSignificant arousal · caution
RedHigh activation · pause and recover
Issued, not pending.
BAM's closed loop and four-state color status system are protected under U.S. Patent 12,109,041 B2, granted October 8, 2024 — a granted claim set covering the method we are bringing to market, on a consumer-owned Apple stack tens of millions already wear daily. The cofounders authored the patent and built the platform.
Convert an issued patent and a finished platform into a launch.
Capital funds the Apple Vision Pro App Store release and the build-out of the Wellness, Therapy, and Performance modes into a subscription product — the recurring-revenue model proven by leading continuous-biometric businesses, without device manufacturing cost or inventory risk. The access gap is not a risk to underwrite but the market itself, and BAM holds the patent on the awareness layer positioned to serve it.
See the opportunity. Request the deck.
This material is for informational purposes only and does not constitute an offer to sell or a solicitation to buy any security. It contains forward-looking statements subject to risks and uncertainties; actual results may differ materially. Market-size figures are third-party analyst estimates that vary by source and date; they describe market and access opportunity only and are not a forecast of BAM's revenue. BAM is a wellness and physiological-awareness training platform. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease or condition. Therapy mode is somatic-awareness practice, not licensed clinical care, and is not a replacement for it. Prospective investors should rely solely on definitive offering documents. Patent: U.S. Patent 12,109,041 B2, issued October 8, 2024.